OSA's Digital Library

Chinese Optics Letters

Chinese Optics Letters


  • Vol. 6, Iss. 12 — Dec. 1, 2008
  • pp: 944–946

Inactivation of bovine immunodeficiency virus by photodynamic therapy with HMME

Huijuan Yin, Yingxin Li, Zhaohui Zou, Wentao Qiao, Xue Yao, Yang Su, and Hongyan Guo  »View Author Affiliations

Chinese Optics Letters, Vol. 6, Issue 12, pp. 944-946 (2008)

View Full Text Article

Acrobat PDF (206 KB)

Browse Journals / Lookup Meetings

Browse by Journal and Year


Lookup Conference Papers

Close Browse Journals / Lookup Meetings

Article Tools

  • Export Citation/Save Click for help


To investigate the effect of photodynamic therapy (PDT) with hematoporphrin monomethyl ether (HMME) on bovine immunodeficiency virus (BIV) can provide the basis theory for photoinactivation of human immunodeficiency virus (HIV). To assess the protection of HMME-PDT on the cell line Cf2Th infected with BIVR29 by 3-(4,5)-dimethylthiahiazol-2-y1-3,5-di-phenytetrazolium bromide (MTT) with power density of 5 and 25 mW/cm2 and energy density from 0.6 to 3 J/cm2. To observe the inhibition of membrane fusion using a new reporter cell line BIVE by fluorescence microscope. HMME-PDT has significant protectant effects on Cf2Th-BIVR29 with both power densities, especially in the group of high power density. Fluorescent microscope shows that there is no significant difference between the group of PDT and control, which means PDT could not inhibit the BIV-mediated membrane fusion.

© 2008 Chinese Optics Letters

OCIS Codes
(170.1530) Medical optics and biotechnology : Cell analysis
(170.2520) Medical optics and biotechnology : Fluorescence microscopy
(170.5180) Medical optics and biotechnology : Photodynamic therapy

Huijuan Yin, Yingxin Li, Zhaohui Zou, Wentao Qiao, Xue Yao, Yang Su, and Hongyan Guo, "Inactivation of bovine immunodeficiency virus by photodynamic therapy with HMME," Chin. Opt. Lett. 6, 944-946 (2008)

Sort:  Author  |  Year  |  Journal  |  Reset


  1. 2007 AIDS epidemic update. December 2007. UNAIDS, Geneva.
  2. E. de Clercq, Biochem. Biophys. Acta 1587, 258 (2002).
  3. L. B. Josefsen and R. W. Boyle, Met. Based Drugs. 2008, 276109 (2008).
  4. X. Ding, Q. Xu, F. Liu, P. Zhou, Y. Gu, J. Zeng, J. An, W. Dai, and X. Li, Cancer Lett. 216, 43 (2004).
  5. G. J. Tobin, W. H. Ennis, D. J. Clanton, and M. A. Gonda, Antiviral Research 33, 21 (1996).
  6. M. Wainwright, H. Mohr, and W. H. Walker, J. Photochem. Photobiol. B 86, 45 (2007).
  7. B. G. Solheim and J. Seghatchian, Transfusion and Apheresis Science 35, 83 (2006).
  8. V. Jauvin, R. D. Alfonso, B. Guillemain, K. Dupuis, and H. J. A. Fleury, Blood Components 45, 1151 (2005).
  9. M. Wainwright, Photochem. Photobiol. Sci. 3, 406 (2004).
  10. D. S. Dimitrov and R. Blumenthal, J. Virol. 68, 1956 (1994).
  11. J. Lenard, A. Rabson, and R. Vanderoef, in Proceedings of Natl. Acad. Sci. USA 90, 158 (1993).
  12. T. Maisch, J. Baier, B. Franz, M. Maier, M. Landthaler, R.-M. Szeimies, and W. Baumler, in Proceedings of Natl. Acad. Sci. USA 104, 7223 (2007).

Cited By

OSA is able to provide readers links to articles that cite this paper by participating in CrossRef's Cited-By Linking service. CrossRef includes content from more than 3000 publishers and societies. In addition to listing OSA journal articles that cite this paper, citing articles from other participating publishers will also be listed.

« Previous Article  |  Next Article »

OSA is a member of CrossRef.

CrossCheck Deposited